[The efficacy of the new bacterial preparation biosporin in treating acute intestinal infections].
The clinico-laboratory study of the new probiotic Biosporin revealed its effectiveness in the treatment of patients with acute enteric infections. The pronounced curative action of the preparation, manifested by the rapid normalization of stool, the disappearance of abdominal pains and the decrease of dysbiosis in the intestine, was demonstrated. The best results were registered after the administration of Biosporin containing 2 x 10(9) microbial cells (Bacillus subtilis and Bacillus licheniformis). Biosporin was well tolerated by the patients, no side effects were observed. Biosporin is recommended for use in medical practice for the treatment of patients with acute enteric infections.
Gracheva
N M
NM
Gabrichevsky Research Institute of Epidemiology and Microbiology, Moscow, Russia.
Gavrilov
A F
AF
Solov'eva
A I
AI
Smirnov
V V
VV
Sorokulova
I B
IB
Reznik
S R
SR
Chudnovskaia
N V
NV
D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001412:Bacillus subtilis; D001430:Bacteriocins / Q000627:therapeutic use; D001685:Biological Factors / Q000627:therapeutic use*; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007410:Intestinal Diseases / Q000188:drug therapy*; D007778:Lactobacillus; D008297:Male; D008875:Middle Aged; D012478:Salmonella Food Poisoning / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D001430:Bacteriocins; D001685:Biological Factors; C091592:biosporin; C008244:lactobacterin